期刊文献+

肺腺癌细胞对谷胱甘肽纳米Fe_3O_4的内吞作用

Endocytosis of lung adenocarcinoma cell on glutathione modified magnetite(Fe_3O_4)nanoparticles
下载PDF
导出
摘要 目的在体外观察人肺腺癌细胞(SPC-A1)对谷胱甘肽(GSSG)修饰的纳米Fe3O4的内吞作用及与培养温度、时间及浓度的关系。方法通过透射电镜(TEM)与普鲁士兰染色法观察SPC-A1细胞对GSSG修饰的纳米Fe3O4的内吞作用。采用原子吸收光谱(AAS)法进行SPC-A1细胞粘附量及内吞量的定量分析。结果TEM结果表明,在4℃下培养24 h后GSSG修饰的纳米Fe3O4吸附于SPC-A1细胞表面;37℃下培养1 h后SPC-A 1细胞可内吞GSSG修饰的纳米Fe3O4细胞数目明显增加。AAS分析表明,SPC-A1细胞表面纳米Fe3O4的粘附量同培养时间及浓度呈正相关。GSSG修饰的纳米Fe3O4浓度较低(0.1或0.4 mg/ml)时,内吞量在24 h后达到饱和;GSSG修饰的纳米Fe3O4浓度较高(0.7或1.0 mg/ml)时,内吞量在72 h后达到饱和,单个细胞内吞量最大可达160 pg。结论SPC-A1细胞对GSSG修饰的纳米Fe3O4的内吞需要能量,内吞量依赖于浓度及培养时间。 Objective To study the relationship between endoeytosis of human lung adenocarcinoma cell line SPC- A1 modified by oxidized Glutathione(GSSG) and culture conditions including culture temperature, time and concentration. Methods The uptake of GSSG- modified Fe3O4 nanopartieles by SPC- A1 cell was observed by transmission electron microscopy (TEM) and Prussian blue staining. The extracellular adhesion or intracellular uptake of GSSC- - modified Fe3O4 nanopartieles were measured by atom absorb spectrum (AAS). Results TEM results indicated that GSSG - modified Fe3O4 nanopartieles adhered on the membrane of SPC - A1 cell after being cultured at 4 ℃ for 1 h or 24 h, but SPC - A1 cell could took up nanopartieles particles after cultured at 37 ℃ for 1 h. Prussian blue staining indicated that SPC - A1 cells containing GSSG - modified Fe3O4 nanopartieles were much more with the prolongation of culture time or the increase of concentration. AAS analysis indicated that the extraeellular adhesion of GSSG- modified magnetic particles was depended on culture time and concentration. The uptake amount of GSSG- modiied Fe3O4 nanopartieles by SPC - A1 cell was saturated after 24 h when the nanopartieles in low concentration (0.1 mg/ml or 0.4 mg/ml), the uptake was saturated after 72 h when the nanoparti- eles in high concentration (0.7 mg/ml or 1.0 mg/ml). The maximal amount per SPC - A1 cell could reach 160 pg. Conclusion The uptake of GSSG - modified Fe3O4 nanoparticles by SPC - A1 cell is energy needed. It depends on the concentration of nanoparticles and saturates at certain time.
出处 《中国公共卫生》 CAS CSCD 北大核心 2007年第1期47-49,共3页 Chinese Journal of Public Health
基金 国家"863"计划项目(2005AA302H10)
关键词 人肺腺癌细胞 谷胱甘肽 FE3O4 内吞作用 human lung adenoeareinoma cell glutathione magenetite( Fe3O4 ) endocytosis
  • 相关文献

参考文献9

  • 1张玉臣,杜永丽,聂翠芳,王薇.还原型谷胱甘肽的临床应用进展[J].社区医学杂志,2005,3(4):26-27. 被引量:10
  • 2任少琳.还原型谷胱甘肽的临床应用[J].中华实用医药杂志,2005,5(4):317-317.
  • 3Jordan A, Scholz R, Klaus MH, et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumorswith magnetic fluid hyperthermia [J ]. Journal of Magnetism andMagnetic Materials, 2001,225 : 118 - 126.
  • 4Sun R, Julia D, Martin LH, et al, Physical and Biological Characterization of Superparamagnetic Iron Oxide and UltrasmaU Superparamagnetic Iron Oxide - Labeled Cells - A Comparison [J ]. In verstigative Radiology, 2005.40(8) :504 - 513.
  • 5马勇杰,李红,许凯黎,古宏晨.人肺腺癌细胞SPC-A1与人胚肺细胞WI-38对纳米颗粒吞噬作用的研究[J].肿瘤,2005,25(1):7-9. 被引量:8
  • 6马明,朱毅,张宇,张东生,唐祖明,张海黔,顾宁.四氧化三铁纳米粒子与癌细胞相互作用的初步研究[J].东南大学学报(自然科学版),2003,33(2):205-207. 被引量:31
  • 7Bernhard Schopf, Tobias Neuberger. Katja Schulze, et al. Methodology description for detection of cellular uptake of PVA coated superparamagnetic iron oxide nanoparticles (SPION) in synodal cells of sheep[J]. Journal of Magnetism and Magnetic Materials, 2005, 293:411-418.
  • 8A Petri - Fink, M ChasteUain, L Juillerat - Jeanneret, et al. Development of funetionalized superparamagnetie iron oxide nanopartielesfor interaction with human cancer cells[J ]. Biomaterials, 2005, 26:2685 - 2694.
  • 9Yong Zhang, Jing Zhang. Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells[J]. Journal of Colloid and Interface Science, 2004, 11: 12 - 21.

二级参考文献31

  • 1韩丽娜,强春倩.还原型谷胱甘肽治疗慢性乙型肝炎疗效观察[J].实用肝脏病杂志,2003,6(4). 被引量:3
  • 2郭亮,刘波,张慎贵.古拉定防治鼻咽癌放疗副反应效果观察[J].山东医药,2004,44(18):54-55. 被引量:3
  • 3何念海,顾长海,马巧玉,何亚玲.还原型谷胱甘肽治疗病毒性肝炎的临床观察[J].临床内科杂志,1996,13(6):27-28. 被引量:57
  • 4[1]Hai Y, Pai V, Chen C J. Development of magnetic device for cell separation [J]. J Magn Magn Mater, 1999,194(1-3):254-261.
  • 5[2]Chen D, Liao M. Preparation and characterization of YADH-bound magnetic nanoparticles[J]. J Molecular Catalysis, 2002,16(5/6):283-291.
  • 6[4]Torchilin V P. Drug targeting[J]. Europ J Pharmaceutical Sci, 2000,11(2):81-91.
  • 7[5]Reimer P, Weissleder R. Development and experimental application of receptor-specific MR contrast media[J]. Der Radiologe, 1996,36(2):153.
  • 8[6]Chouly C, Pouliquen D, Lucet I, et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution [J]. J Microencapsulation, 1996,13(3):245-255.
  • 9[7]Chan D C F, Kirpotin D, Bunn P A. Synthesis and evaluation of colloidal magnetic iron-oxides for the site-specific radiofrequency induced hyperthermia of cancer[J]. J Magn Magn Mater, 1993,122(8):374-379.
  • 10[8]Jordan A, Wust P, Scholz R, et al. Scientific and clinical applications of magnetic carriers[M]. New York: Plenum Press, 1997. 569-575.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部